Contact this Provider:
- Hepatology
- Gastroenterology
- abdominal pain
- abnormal liver function
- alagille syndrome
- alcoholic cirrhosis
- alcoholic encephalopathy Show All
- abdominal pain
- abnormal liver function
- alagille syndrome
- alcoholic cirrhosis
- alcoholic encephalopathy Show All
Board-certified in gastroenterology and internal medicine, James H. Lewis, MD, has spent more than 30 years treating all forms of chronic and acute liver disease as a sub-specialty in the Washington, DC, area. Dr. Lewis is Professor of Medicine at Georgetown University School of Medicine, and Director of Hepatology in the Division of Gastroenterology. He currently serves as Associate Director of the Gastroenterology Fellowship training program of the combined MedStar Georgetown University Hospital, MedStar Washington Hospital Center and the DC Veteran's Affairs Medical Center.
A recognized local and national expert on the management of hepatitis B, hepatitis C and drug induced liver disease, Dr. Lewis is widely published in the profession's most prestigious clinical journals. He also serves as a reviewer for multiple journals and on editorial boards. The author of several books and numerous book chapters, Dr. Lewis is a frequent lecturer at the regional and national level.
In addition to direct patient care, Dr. Lewis has extensive consulting experience with the FDA and pharmaceutical manufacturers on a variety of liver-related conditions. His special research interests include viral hepatitis and drug induced liver injury. Dr. Lewis is committed to his patients and often cares for those dealing with very complex liver conditions, including acute liver failure, cirrhosis, and people who have failed prior treatment for hepatitis B and C.
- Fellowship Program: MedStar Georgetown University Hospital (1980)
- Residency Program: Kings County Hospital Center (1978)
- Internship Program: Baylor College of Medicine Affiliated Hospitals (1976)
- Medical School: SUNY Downstate Medical Center College of Medicine (1975)
- Board Certification: American Board of Internal Medicine, Gastroenterology
- Board Certification: American Board of Internal Medicine, Internal Medicine
- Sarges P, Steinberg JM, Lewis JH. Drug-induced liver injury: highlights from a review of the 2015 literature. Drug Safety 2016 DOI 10.1007/s40264-016-0427-8.
- Stine JG, Lewis JH. Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Review of Gastroenterology & Hepatology 2016; 10(4): 517-36.
- Lewis JH. The art and science of diagnosing and managing DILI in 2015 and beyond. Clinical Gastroenterology and Hepatology 2015; 13 (12): 2173-89.
- Hahn KJ, Morales SJ, Lewis JH. Enoxaparin induced liver injury: Case report and review of the literature and the FDA Adverse Event Reporting System (FAERS). Drug Safety Case Reports 2015; 2:17.
- Baba TR, Lewis JH. Comparison of four different colonic bowel preps in 3595 patients at a university center: a real life experience. Journal of Gastroenterology and Hepatology Research. 2016 June; 5(3): 2077-2081.
- 3800 Reservoir Road NorthwestWashington, DC 20007
Main Hospital, 2nd Floor
View MapPhone: 202-444-1671
Fax: 877-303-1462
Accepting New Patients
- MedStar Georgetown University Hospital
- Georgetown University Hospital Gastroenterology Fellows Award for excellence in teaching Residents and Fellows
- Best Doctors in America
- AMA Physician's Recognition Award
- Elected to Fellowship in the American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association and the American College of Physicians
